Legal & General Group’s Apyx Medical APYX Stock Holding History

Legal & General Group’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,391	Closed	-$22K	–	3527
2022 Q1	$22K	Hold	3,391	–	–	﹤0.01%	3208
2021 Q4	$43K	Buy	3,391 +31	+0.9%	+$434	﹤0.01%	3066
2021 Q3	$47K	Hold	3,360	–	–	﹤0.01%	2990
2021 Q2	$35K	Buy	3,360 +782	+30%	+$7.75K	﹤0.01%	3072
2021 Q1	$25K	Sell	2,578 -552	-18%	-$5.52K	﹤0.01%	3035
2020 Q4	$23K	Hold	3,130	–	–	﹤0.01%	3030
2020 Q3	$15K	Sell	3,130 -1,434	-31%	-$7.1K	﹤0.01%	3068
2020 Q2	$25K	Hold	4,564	–	–	﹤0.01%	2963
2020 Q1	$16K	Sell	4,564 -1,165	-20%	-$7.82K	﹤0.01%	2983
2019 Q4	$48K	Buy	5,729 +178	+3%	+$1.29K	﹤0.01%	2823
2019 Q3	$38K	Hold	5,551	–	–	﹤0.01%	2849
2019 Q2	$33K	Buy	+5,551	New	+$30.2K	﹤0.01%	2959

Other funds holding APYX

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Cowen and Company New York $2.97B AUM 105.25% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PVI

Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return

KLC

Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.89B AUM 151.53% 1-Year Est. Return

Invenire Partners Ridgefield, Connecticut $65.4M AUM 18.1% 1-Year Est. Return

Legal & General Group's APYX Position: Q2 2022 in Review

Legal & General Group sold out of Apyx Medical (APYX) in Q2 2022, closing a stake of 3,391 shares — an estimated $22K sold.

Legal & General Group first reported a position in APYX in Q2 2019 and held it in 12 quarters. The position peaked at $48K in Q4 2019. 63 funds tracked by Wall St. Rank hold APYX as of Q2 2022.

Legal & General Group reported no remaining Apyx Medical position as of Q2 2022 after selling out during the quarter.
Legal & General Group sold 3,391 Apyx Medical shares in Q2 2022, an estimated $22K.
Legal & General Group first reported a position in Apyx Medical in Q2 2019 and held it in 12 quarters.
Legal & General Group's Apyx Medical position peaked at $48K in Q4 2019.
63 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2022.

Based on Legal & General Group's 13F filing for Q2 2022, filed 22 Aug 2022.